Mangoceuticals Stock (NASDAQ:MGRX)
Previous Close
$2.19
52W Range
$1.32 - $7.67
50D Avg
$1.77
200D Avg
$2.45
Market Cap
$22.44M
Avg Vol (3M)
$158.29K
Beta
2.46
Div Yield
-
MGRX Company Profile
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.